首页> 外文期刊>Leukemia Research Reports >Management of multiple myeloma during COVID-19 pandemic
【24h】

Management of multiple myeloma during COVID-19 pandemic

机译:Covid-19流行期间多发性骨髓瘤的管理

获取原文
       

摘要

At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.
机译:在2019年底,一部小型冠状病毒被鉴定为武汉湖北省武汉肺炎案件的原因。 2020年1月30日,世界卫生组织(世卫组织)宣布Covid-19爆发了国际问题的公共卫生应急,并于2020年3月开始将其作为大流行表征。 导致Covid-19的病毒在2020年2月指定了严重的急性呼吸综合征冠状病毒2(SARS-COV-2),世界卫生组织指定了疾病Covid-19,它代表2019年冠状病毒疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号